New Rhein Healthcare Investors, LLC β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
Neuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.
BiotechDeep TechHealthtechMedical DevicesLouisville, US
David Jackson(Executive Officer, Director)Gino DiSciullo(Director)Randy Hubbell(Director)
Board seatGreg ParekhIvan GergelΒ· per SEC Form D
Co-investorsCentral Texas Angel Network
Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.
BiotechHealthtechLongevityPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)
Board seatIvan GergelΒ· per SEC Form D
Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalSeroba Life SciencesAgent Capital+2 more
Irvine, CA based Alzheimer's drug company
BiotechWashington, US
Thomas N. Chase(Executive Officer, Director)Douglas Ingram(Executive Officer, Director)John M. Siebert(Executive Officer, Director)Kathleen Clarence-Smith(Executive Officer)
BoardNayan Greg Parekh(Director)John M. Reher(Director)in
Co-investorsAndera PartnersBrain Trust Accelerator Fund
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
AlveusAmerican Injectables Inc.Butterfly MedicalCorsair PharmaNovagali PharmaSAYVAA PharmaSofthaleTheranica
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.